Search
for
Sort by
Research 811–840 of 1000+
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
- Is There Any Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss?
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Medicinal and edible plant Allium macrostemon Bunge for the treatment of testosterone-induced androgenetic alopecia in mice
- A study on clinical correlation with Hyperinsulinemia in polycystic ovary Syndrome
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single‐blinded, active‐controlled trial
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- The circulating dihydrotestosterone/testosterone ratio is increased by gut microbial 5α-reductase activity in females
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- Acne-Associated Syndromes
- A Case of Ovarian Hyperthecosis in a Postmenopausal Woman
- Comorbidities in Androgenetic Alopecia: A Comprehensive Review
- Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
- Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Cardiovascular effects of hormone therapy for prostate cancer
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
- Psychosocial and financial impact of facial hair among female patients of hirsutism: A cross‐sectional study
- Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report
- An Indian Evidence-Based Study of Prevalence, Phenotypic Features, Lifestyle Modifications of Polycystic Ovarian Syndrome Patients
- Uncertainty and Sensitivity Analysis of Hair Growth Duration in Human Scalp Follicles Under Normal and Alopecic Conditions
- Clinical characteristics and factors associated with different BASP subtypes of androgenetic alopecia
- Multivariate Profiles of Female Sexual Function: A Cluster Analysis of FSFI Domains in Women with and Without PCOS
- Postmenopausal hyperandrogenism of ovarian origin
- Genetic Variants and Lifestyle Factors in Androgenetic Alopecia Patients: A Case–Control Study of Single Nucleotide Polymorphisms and Their Contribution to Baldness Risk
- A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial
- PRECISE Scale: a quantitative classification for androgenetic alopecia and its application to hair transplantation